Serum amyloid A protein in acute viral infections

Abstract

Concentrations of serum amyloid A protein (SAA) were measured in 254 children with viral diseases, including measles, varicella, rubella, mumps, echo-30 meningitis, chronic hepatitis B and C, and in eight with Kawasaki disease. Latex agglutination nephelometric immunoassay was used for assaying SAA. In 191 out of 195 patients (98%), SAA concentrations became markedly raised in the acute phase of the viral disease: measles (97%), varicella (100%), mumps (95%), and echo-30 meningitis (99%) with mean titres of 82.4, 80.5, 60.2, 75.2, and 101.1 μg/ml respectively. This increase in SAA was followed by a rapid return to normal concentrations (<5 μg/ml) during convalescence. Remarkably higher concentrations of SAA (mean 1630 μg/ml) were detected in the acute phase of patients with Kawasaki disease, but in most of the children with chronic hepatitis B or C, the titres of SAA remained normal. There was no close correlation between SAA and serum concentrations for α1-acid glycoprotein, β2-microglobulin, transferrin, and IgG. There was a clear correlation between SAA and C reactive protein concentrations, although SAA showed a greater incremental change than C reactive protein in the acute phase. In the acute phase of these viral diseases, 56% of the patients had raised SAA concentrations (≥5 μg/ml) with normal C reactive protein concentrations (<5 μg/ml). These results indicate that SAA could be useful as an inflammatory marker in children with acute viral infections.